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Background:  An increasing body of literature is exploring whether the age of the recipient 
of health care should be a criterion in how health care resources are allocated. The existing 
literature is constrained both by the relatively small number of age comparison groups within 
preference elicitation studies, and by a paucity of methodological robustness tests for order 
and framing effects and the reliability and transitivity of preferences that would strengthen 
confidence in the results. This paper reports the results of a study aimed at estimating 
granulated age-related weights for health gains across the age spectrum that can potentially 
inform health care decision-making.  
Methods:  A sample of 2500 participants recruited from the health care consumer panels of a 
social research company completed a person trade-off (or ‘matching’) study designed to 
estimate age-related weights for 5 year and 10 year life extensions. The results are presented 
in terms of matrices for alternative age comparisons across the age spectrum.  
Results:  The results revealed a general, although not invariable, tendency to give more 
weight to health gains, expressed in terms of life extensions, to younger age groups. In over 
85% of age comparisons, the person trade-off exercises revealed a preference for life 
extensions by the younger of the two age groups compared. This pattern held regardless of 
the method of aggregating responses across study participants. Moreover, the relative weight 
placed on life extensions by the younger of the two age groups was generally, although not 
invariably, found to increase as the age difference between the comparator age groups 
increased. Further analyses revealed that the highest mean relative weight placed on life 
extensions was estimated for 30 year olds when the ratio of means method was used to 
aggregate person trade-off responses across study participants. The highest mean relative 
weight placed on life extensions was estimated for 10 year olds for 5 year life extensions and 
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for 30 year olds for 10 year life extensions, when the median of individual ratios method was 
used to aggregate person trade-off responses across study participants. Methodological tests 
framed around alternative referents in the person trade-off questions and the stability of 
preferences had no discernible effects on the study results.  
Conclusion:  This study has produced new evidence on age-related weights for health gains 






Key points for decision makers 
 
 This study provides evidence that individuals tend to give more weight to health 
gains, expressed in terms of life extensions, to younger age groups. 
 The highest mean relative weight placed on life extensions was evident for older 
children and young adults. 
 The results of this study should inform deliberations on whether health gains should 
be weighted according to age in health care decision-making. Nevertheless, they 
should be subject to re-retesting. Moreover, future research should aim to estimate 
distributional weights for health gains according to combinations of characteristics of 







Economic evaluation has increasingly been used to inform the health care decision-making 
processes of government agencies throughout the industrialised world [1-3]. Decision-makers 
commonly seek to maximise health benefits given constrained health care resources. A dominant 
maximand proposed for health economic evaluation remains the quality-adjusted life year 
(QALY), a preference-based measure of health outcome that combines length of life and health-
related quality of life in a single metric [4]. In economic evaluation, the incremental cost-
effectiveness of a health intervention or programme is commonly compared to a cost-
effectiveness threshold, a pre-determined value for money benchmark for the unit of health gain 
of interest (e.g. a QALY gain). A health intervention or programme with an incremental cost-
effectiveness ratio (ICER) that falls below the threshold is deemed by decision-makers to offer 
good value for money and is generally recommended on cost-effectiveness grounds. In contrast, a 
health intervention or programme with an ICER that falls above the threshold is deemed by 
decision-makers not to offer good value for money and is generally rejected on cost-effectiveness 
grounds. In England and Wales, the National Institute for Health and Care Excellence (NICE) 
applies a threshold of £20,000-£30,000 per QALY gained [5, 6]. In other European countries, 
there are few public statements about value for money benchmarks for an additional QALY, 
although these might rest between $10,000 and $50,000 [7]. In the US, the threshold has been 
claimed to rest at $50,000 per QALY gained, although the scientific basis for this threshold 
appears to be nebulous with no evidence of its consistent use as a tool for informing the 
regulatory and reimbursement decisions of federal programmes [8]. Moreover, the bases for these 
thresholds largely remain unclear, or at least under-specified, particularly with regards to how 




     A methodological concern in the health economics literature, which has gained real policy 
traction, surrounds whether the health gain of interest (e.g. a QALY gain) should be given equal 
value in health care decision-making across different population groups.  Decision-making bodies 
have commonly returned to the position that an additional unit of health should be of equal value 
regardless of the socio-demographic characteristics of the recipient or their pre- or post-treatment 
levels of health. Nevertheless, many decision makers take the characteristics of the beneficiaries 
of interventions into account, at least in their deliberations [6]. Indeed, research studies have been 
funded with the explicit remit of identifying relative weights that might be attached to health 
gains derived by different beneficiaries in the event of policy makers’ support for differential 
weighting [10, 11]. Empirical evidence in the literature suggests that some people may be willing 
to give greater priority to certain population groups in health care decision-making, such as those 
in the poorest health states [12], those with more urgent conditions [13], those from lower social 
classes [14] and those with dependents [15], and less priority to those deemed responsible for 
their ill-health [16]. Overviews of the empirical evidence on relative weights that might be 
attached to health gains derived by different beneficiaries can be found elsewhere [10, 11]. 
     In this context, an increasing body of literature is exploring whether the age of the 
recipient of health care might be considered a relevant criterion in how health care resources 
are allocated. A number of revealed preference studies suggest that the value individuals 
place on reducing health risks or achieving health gains may be higher for children than for 
adults [17-20]. However, many of the values estimated in the revealed preference literature 
are based on choices made by parents on the part of their families and consequently are likely 
to be driven by the effects of self-interest [21]. Perhaps more pertinent evidence is provided 
by stated preference studies that ask study participants to act as the social decision maker 
motivated by some notion of what is good for the society of which they are part.  A number 
of stated preference studies have focussed on potential age-related weights for health gains 
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that might be applied within an economic evaluation framework [22-30]. This literature is 
constrained both by the relatively small number of age comparison groups within studies, 
with the number of ages assessed varying between two [29] and five [23, 26-28], and by a 
paucity of methodological robustness tests for order and framing effects and the reliability 
and transitivity of preferences that would strengthen confidence in the results. Furthermore, 
few attempts have been made to disentangle different forms of ageism within individuals’ 
preference structures; for example, ‘health maximisation ageism’ [28] or ‘utilitarian ageism’ 
[31], where preference is given to the treatment of younger patients simply because they are 
expected to live longer after treatment; ‘productivity ageism’[28], where preferences are 
determined by the recipients’ productivity potential; or ‘fair innings ageism’ [28] (or 
‘egalitarian ageism’ [31]), where preferences are driven by an aversion to inequality in age of 
death.  
     This paper builds on the current literature by presenting the results of a person trade-off 
study that calculated age-related weights for health gains across the entire lifespan at a more 
granulated level than has hitherto been achieved. In the process, it addresses a number of 




2.1 Sample and data collection 
 
We recruited a sample of 2500 participants from the health care consumer panels of a social 
research company (Synovate Healthcare) during February and March 2011. Members of the 
health care consumer panels received individualised e-mails inviting them to participate in an 
internet survey. Individuals who responded positively to the initial invitation subsequently 
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received an on-line link to the survey, which they were asked to complete. The survey had been 
developed according to good practice principles for on-line research [32], and subsequently 
piloted amongst a convenience sample of staff and students at the University of Warwick. 
Straightforward unambiguous non-open-ended questions, without requirement for free text entry, 
were used throughout the survey. The study sample was restricted to residents of the United 
Kingdom, aged at least 18 years of age. Each participant was compensated to the value of £3 for 
their time.  
 
2.2 Research design 
 
The research design built upon the methods of the UK SVQ Study [10], which included a 
person trade-off study (or ‘matching’ study based on nomenclature in the transport literature) 
aimed at estimating the relative weights to be attached to health gains according to 
characteristics of recipients of those gains. The main distinguishing design features between 
the person trade-off component of the UK SVQ Study and our study were (i) health gains in 
the former were delineated in terms of QALYs (expressed in terms of age, severity levels and 
QALY components) whereas health gains in our study were delineated in terms of life years 
gained; and (ii) the age-related beneficiaries of health gains in the former were grouped into 
four broad age groups (0-20, 20-40, 40-60, 60-80), whereas in our study they were described 
at a more granulated level across the age spectrum.  
     In our study, different stages in the life cycle were represented in two principal ways; first, 
by 19 ages that increased incrementally by five years between birth and 90 years of age 
(newborns, 5, 10, 15, 20…90); and, second, by 10 ages that increased incrementally by ten 
years between birth and 90 years of age (newborns, 10, 20, 30…90). The former generated an 
age matrix of 171 possible age comparisons (age matrix 1; e.g. 5 v 35, 20 v 65, etc.), whilst 
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the latter generated an age matrix of 45 possible age comparisons (age matrix 2; e.g. 10 v 30, 
10 v 70, etc.). It was considered that a further granulation of the life cycle into yearly 
intervals would not have generated additional meaningful information. Study participants 
were asked to imagine themselves as the social decision-maker for a resource-constrained 
health system. They were each asked to complete eight person trade-off questions that 
considered pairs of health programmes (A and B) that targeted different age groups. For each 
person trade-off question, they were initially asked to choose one of two programmes 
targeted at different age groups of equal size, assuming that (i) the programmes would extend 
the lives of recipients for a fixed period in full health after which they would die, (ii) the 
programmes were of equal cost, and (iii) that resources were only available to fund one 
programme. In keeping with the methods of the UK SVQ Study [10], the initial choice 
between the two programmes was forced; one of the two programmes had to be selected. 
Participants were subsequently asked to indicate how many people would have to be treated 
by the programme targeted at their more preferred age group (relative to a fixed number of 
people treated by the programme targeted at their less preferred age group) for the two 
programmes to be of equal social value. A ‘ping-pong’ method that oscillated up and down 
the scale was used to converge on an indifference point between the more preferred and less 
preferred age groups. The values of the upper and lower ends in each of the ping pong 
iterations mirrored those adopted by the person trade-off component of the UK SVQ Study 
[10], with a maximum of six iterations possible within each person trade-off question. 
Previous research indicates that the ‘ping-pong’ method may be less prone to anchor point 
bias compared to the alternative titration variant where the values of one option are steadily 
varied in the same direction.[33] For each study participant, six of the person trade-off 
questions were selected at random using computer-generated random numbers from age 
matrix 1; the fixed period of health gain assumed for these questions was an extra 5 years of 
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life. A further two person trade-off questions were selected at random using computer-
generated random numbers from age matrix 2; the fixed period of health gain assumed for 
these questions was an extra 10 years of life. An illustrative example of a person trade-off 
question is provided in On-Line Appendix I. 
     As a warm up to the person trade-off questions, study participants were also asked to rank 
ten hypothetical age groups (newborns, 10, 20, 30…90) in the order in which they would 
choose to give an extra 5 years of life. In addition, study participants described their own 
health status at the point of completion of the survey using the EuroQol EQ-5D measure [34] 
and the categorical self-reported health status (very good, good, fair, bad, very bad) and long-
standing illness (yes, no) measures routinely incorporated into the annual Health Survey for 
England . Socio-demographic data provided by the study participants included their age, 
gender, marital status, ethnicity, employment status, annual income, education status, area of 
residence, and whether they had children and, if so, how many.  
     The survey questions were ordered as follows: socio-demographic measures, self-reported 
health measures, ranking exercises and, finally, person trade-off questions. 
 
2.3 Methodological considerations within research design 
 
The use of the person trade-off technique as a preference elicitation tool for informing health 
care resource allocation raises a number of methodological issues. We addressed two of these 
methodological issues in our study. First, the reference number of individuals included in the 
initial iteration of each person trade-off question may influence responses, i.e. respondents 
may be concerned about the absolute difference between the numbers of individuals in each 
age group as well as the relative difference between them. Previous studies have framed 
person trade-off questions with a reference number of individuals ranging from 1 [35] to 
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1000 [36]. In order to assess whether our estimated age-related weights for health gains were 
influenced by the framing of the person trade-off questions, the reference number of 
individuals in each age group was set at 100 for one half of the study participants (n=1250) 
and at 1000 for the other half of study participants (n=1250). Study participants were 
randomly allocated to alternative referents using computer-generated random numbers. 
Second, little evidence currently exists on whether the person trade-off technique generates 
stable responses, given unchanged preferences, over time [37-39]. If the technique is to be 
promoted as an operational tool that can inform health care resource allocation, evidence is 
required on its test-retest reliability. In order to assess the stability of the preferences of our 
study sample, all study participants were asked upon completion of the first survey whether 
they would complete a second (retest) survey. The first 500 individuals (equivalent to one 
fifth of the sample) who responded positively to this request were asked to complete identical 
questions, in the same order and using the same on-line format, approximately one week after 
the first survey. These individuals did not have recourse to their previous responses. Each 
participant was compensated to the value of a further £3 for their input into the retest survey.  
 
2.4 Data analysis 
 
A detailed statistical analysis plan was followed. The socio-demographic and health 
characteristics of the entire study sample and the sample who participated in the test-retest 
reliability exercise were summarised using descriptive statistics. The results of the ranking 
exercise were presented in terms of the number and proportion of study participants who gave a 
particular rank to each of the ten hypothetical age groups (newborns, 10, 20, 30…90). Aggregate 
rankings were summarised as Borda scores whereby the first through tenth ranked ages were 
given scores of ten through 1, and the scores summed across the respondents for each age group 
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[28, 40]. The age group with the highest total Borda score was ranked first, the age group with 
second highest total Borda score was ranked second, and so forth. In order to assess whether the 
results of the ranking exercise was influenced by the age and parental status of study participants, 
total Borda scores were also calculated for three age sub-groups of study participants: those less 
than 40 years of age (n=1367), those aged 40-49 years (n=791), and those at least 60 years of age 
(n=342); and for two parental status sub-groups of study participants: parents (n=1152) and non-
parents (n=1348). 
     There is no single preferred measure for aggregating person trade-off ratios across individuals. 
Taking the arithmetic mean of individual ratios suffers from an asymmetric property and 
produces inconsistent results [10]. Following the methodology of the UK SVQ study, we adopted 
two methods for aggregating person trade-off responses for each age comparison across study 
participants [10]. First, we adopted the ratio of means method whereby, at an individual level, the 
preferred age group was assigned a value of 1 and the less preferred age group a value equal to 
the number of people in the preferred age group divided by the number of people in the less 
preferred age group. Means of values for each age group were estimated across study participants 
and the ratio of those means calculated. Second, we adopted the median of individual ratios 
method whereby we estimated a ratio for each study participant and, subsequently, estimated the 
median value across study participants. See On-Line Appendix II for worked examples of the 
ratio of means method and the median of individual ratios method and illustrations of their 
respective symmetrical properties. Both methods were used to estimate relative age weights for 5 
year life extensions for all age comparisons delineated by age matrix 1 and for 10 year life 
extensions for all age comparisons delineated by age matrix 2. 
     We used an F-test to test for constancy in the relative social value of life extensions for 
different ages. We also tested for consistency of values via chaining tests performed on 20 
random non-adjacent pairings covered by both age matrices; consistency requires that the value 
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(v) placed on life extensions covered by consecutive sets of adjacent pairings should be consistent 
with values placed on life extensions covered by non-adjacent pairings, such that Vavb*Vbvc=Vavc 
(where, in this context, a, b and c represent alternative ages within the age matrices). 
     In 40 random age comparisons (20 drawn from age matrix 1 and 20 drawn from age matrix 2), 
the Student’s t test procedure was used to compare relative weights for health gains by the 
reference number of individuals in the person trade-off questions (100 v 1000). Similarly, in 20 
random age comparisons, the Student’s t test procedure (assuming unequal variance) was used to 
test individual-level mean ratio differences by period of life extension (5 years v 10 years). The 
latter analyses were restricted to individuals for whom both 5 year and 10 year life extension 
person trade-off questions were answered for each random age comparison. 
     For the 500 study participants who undertook the second (retest) survey, the test–retest 
reliability of person trade-off responses was assessed by calculating the intraclass correlation 
coefficient (ICC) [41]. ICC values of between 0 and 0.2 are considered to represent poor 
agreement, between 0.3 and 0.4 fair agreement, between 0.5 and 0.6 moderate agreement, 
between 0.7 and 0.8 strong agreement, and >0.8 excellent agreement [42]. Separate analyses were 
conducted for all 500 study participants, 250 participants for whom the reference number of 
individuals in the person trade-off questions was 100, and 250 participants for whom the 
reference number was 1000. The F-test was used to test the null hypothesis that the sample ICC is 
0.  
     All analyses were performed using STATA software (StataCorp. 2009. Stata Statistical 
Software: Release 11. College Station, TX: StataCorp LP). Differences were considered 







3.1 Study sample 
 
The survey took an average of 21 minutes to complete (median duration: 15 minutes). The 
baseline characteristics of the study participants are described in table I. The mean (standard 
deviation (SD)) age of the study sample was 40.5(14.3) years. The majority of the sample was 
female (69.0%), married (51.2%), of white ethnic origin (92.1%), in paid employment or self-
employed (63.0%) and had a highest educational qualification below degree or higher national 
certificate or higher national diploma level (60.7%). The mean EQ-5D utility score for the study 
participants, generated by applying the York A1 tariff to each set of responses to the EQ-5D 
descriptive system [43], was 0.796 (SD: 0.286). The numbers (%) of study participants who 
described their own health as very good, good, fair, bad or very bad were 567(22.7%), 
1260(50.4%), 562(22.5%), 101(4.0%) and 10(0.4%), respectively, whilst the number (%) of study 
participants who reported a long-standing illness was 911(36.4%). 
 
3.2 Ranking exercises 
      
Table II shows how the study participants ranked the ten hypothetical age groups in the 
ranking exercise. Over half (54.4%) of the study sample ranked newborns first in the order in 
which they chose to give an extra 5 years of life. Broadly speaking first placed rankings 
decreased monotonically with increasing age of the recipient of the programme, although a 
higher proportion of study participants gave a first ranking to 90 year olds compared to 80 
year olds (1.9% v 0.4%). The total Borda score was higher for 10 year olds than for newborns 
(20,079 v 19,277), but decreased monotonically thereafter with increasing age of the 
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recipient, declining to 5592 for 90 olds. The same pattern for the total Borda scores was 
observed when the study sample was divided into three sub-groups that differed by age and 
into two sub-groups that differed by parental status, of study participants (figure I). 
 
3.3 Person trade-off exercises 
      
Table III summarises the person trade-off generated relative age weights for 5 year life 
extensions for each of the 171 possible age comparisons covered by age matrix 1. The left 
hand number in each cell (signifying the relative weight attached to a life extension for 
individuals of the age described by the row heading relative to individuals of the age 
described by the column heading) exceeded 1 in 155 (90.6%) age comparisons for the ratio of 
means method (values in upper half of each cell) and in 158 (92.4%) age comparisons for the 
median of individual ratios method (values in lower half of each cell); for these age 
comparisons, a preference was given to life extensions by the younger age group. A general 
(although not invariable) pattern of increasing magnitude of left hand numbers as one 
progresses to the right of the age grid can be observed. This suggests that the relative weight 
placed on life extensions by the younger of two age groups generally increases as the age 
difference between the age groups increases.  
     The person trade-off generated relative age weights for 10 year life extensions for each of 
the 45 possible age comparisons covered by age matrix 2 are summarised in table IV. As with 
the relative age weights for 5 year life extensions, a general pattern of preference given to life 
extensions by the younger of the two age groups in each age comparison emerged; this was 
the case in 39 (86.7%) age comparisons for the ratio of means method and in 40 (88.9%) age 
comparisons for the median of individual ratios method. Moreover, a general pattern of 
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increasing relative weights placed on 10 year life extensions by the younger of the two age 
groups as the age difference between the age groups increased also emerged. 
      The F-test rejected the assumption of constancy in the relative social value of life 
extensions for different ages (p>0.05). For the ratio of means method, 30 years of age was set 
as the referent in table V (online appendix III) for both 5 and 10 year life extensions as it 
emerged with the highest mean relative age weight across age comparisons in both age 
matrices; table III where there were 18 possible age comparisons for each age group and table 
IV where there were 9 possible age comparisons for each age group. Relative weights for life 
extensions by other age groups can be inferred in this summary table. For example, using the 
ratio of means methods, a weight of 0.91 can be inferred for 5 year life extensions by 15 year 
olds relative to the referent. For the median of individual ratios method, 10 years of age was 
set as the referent for 5 year life extensions as it emerged with the highest mean relative age 
weight across age comparisons in table III; whilst for 10 year life extensions, 30 years of age 
was set as the referent as it emerged with the highest mean relative age weight across age 
comparisons in table IV.  
 
3.4 Methodological tests 
      
The results of the chaining tests performed on 20 random non-adjacent pairings across age 
matrices 1 and 2 revealed that in 14 cases the values implied by chaining were more extreme 
than those derived directly (online appendix IV). However, in 12 of the 20 chaining tests 
performed, the values implied by chaining fell within 10% of those derived directly. In all 40 
random age comparisons, the Student’s t test procedure revealed no significant differences in 
relative weights for health gains by the reference number of individuals in the person trade-
off questions (100 v 1000) (online appendix V). Table VI summarises the individual-level 
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mean ratio differences by period of life extension (5 years v 10 years) for those individuals 
who answered both 5 year and 10 year life extension person trade-off questions for the same 
age groups. No significant differences were observed in 18 of the 20 random age 
comparisons. 
     The baseline characteristics of the 500 study participants who undertook the second 
(retest) survey broadly reflected those of the larger sample. The retest survey took an average 
of 14 minutes to complete (median duration: 15 minutes). The results of the test-retest 
reliability exercises are summarised in table VII. The results are further stratified into two 
sub-groups; the first for whom the reference number of individuals in each age group was set 
at 100 (n=250) and the second for whom it was set at 1000 (n=250). For each group, the 
mean relative weight generated by each ordered person trade-off question increased in value 
between test and retest. For subjects with a referent of 100 individuals, the ICCs revealed 
strong agreement (0.7-0.8) between values at test and retest for three of the eight person 
trade-off questions, and excellent agreement (>0.8) for five of the eight person trade-off 
questions. For subjects with a referent of 1000 individuals, the ICCs revealed strong 
agreement for four of the eight person trade-off questions, and excellent agreement for the 
remaining four. For all test-retest analyses, the F-test rejected the null hypothesis that the 
sample ICC is 0 (p<0.001). 
 
4. Discussion  
 
In this paper, we report the results of a person trade-off (or ‘matching’) study aimed at 
estimating granulated age-related weights for health gains across the age spectrum that can 
potentially inform health care decision-making. The results revealed a general, although not 
invariable, tendency to give more weight to health gains, expressed in terms of life 
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extensions, to younger age groups. In over 85% of age comparisons, the person trade-off 
exercises revealed a preference for life extensions by the younger of the two age groups 
compared. This pattern held regardless of the method of aggregating responses across study 
participants. Moreover, the relative weight placed on life extensions by the younger of the 
two age groups was generally, although not invariably, found to increase as the age difference 
between the comparator age groups increased. Further analyses revealed that the highest 
mean relative weight placed on life extensions was estimated for 30 year olds when the ratio 
of means method was used to aggregate responses across study participants. The highest 
mean relative weight placed on life extensions was estimated for 10 year olds for 5 year life 
extensions and for 30 year olds for 10 year life extensions, when the median of individual 
ratios method was used to aggregate responses across study participants. 
     Comparison of our results with those of other studies are constrained by a number of 
factors, including considerable diversity of methods across studies, such as the preference 
elicitation technique, differences in the age profiles of the recipients of health gain, 
differences in the framing of health gains, and differences in the characteristics of study 
participants. Revealed preference studies have estimated monetary valuations for the life-
saving benefits of interventions, policies and regulations based on individuals’ real world 
choices between alternatives that differ in mortality risk and monetary consequences. A 
number of these revealed preference studies suggest that the value individuals place on 
reducing health risks or achieving health gains, often expressed in terms of a monetary value 
of statistical life, is higher for children than for adults [17-20]. In all of these studies, values 
were only derived for between two and four age groups, each delineated in broad terms. 
Moreover, separating out altruistic preferences for the health of one’s own children or family 
members is problematic for many of these revealed preference studies. 
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     Perhaps more pertinent evidence to our research question is provided by other stated 
preference studies that asked participants faced with a resource-constrained health system to 
take on the role of citizens rather than consumers. The studies varied considerably in their 
stated preference elicitation technique, age profiles of the recipients of health gain, framing of 
health gains, and size and composition of study samples, which limits comparisons between 
studies. Notably, the number of ages assessed varied between two [29] and five [23, 26-28]. 
In nine of 14 studies, preference was generally expressed for health gains by the youngest age 
group assessed [22, 24, 27-31, 44, 45]; in the remaining five studies [10, 23, 25, 26, 46] 
preference was generally expressed for health gains by the second youngest age group 
assessed. It should be noted, however, that the results of these stated preference studies 
generally contrast with the deliberations of NICE’s Citizen’s Council, which considered that 
age should not be a criterion in how health care resources are allocated [47]. 
     Our study was designed to address methodological concerns raised by the use of the 
person trade-off technique as a preference elicitation tool. In the first survey of the full study 
sample, computer-generated random numbers were used to determine the order of person 
trade-off questions, thereby minimising the role of order effects in the preference elicitations 
[48]. Study participants were also randomly allocated to alternative reference number of 
individuals using computer-generated random numbers in order to account for possible 
framing effects. Adopting alternative referents in the person trade-off questions had no 
discernible effects on the study results. Moreover, tests of reliability of preferences revealed 
either strong or excellent agreement between values at test and retest in a large study sub-
sample. The results of the methodological tests performed generate confidence in the results 
of the person trade-off exercises. Nevertheless, it should be noted that other methodological 
tests, such as tests of cardinal transitivity [36], remained outside of the scope of our study. 
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     A number of factors, over and above those common to stated preference studies that ask 
hypothetical questions, need to be considered when interpreting our results. First, we cannot 
claim that our study sample is representative of the population of the United Kingdom. Our 
study sample was, for example, predominantly female and reported a lower mean EQ-5D 
utility score and a higher rate of long-standing illness than reported in the Health Survey for 
England, the annual cross-sectional national survey commissioned by the Department of 
Health with the view to monitoring trends in the English population’s health. Nevertheless, 
our study sample was broadly distributed across a range of socio-demographic, geographic 
and health variables and this is, to our knowledge, the largest preference elicitation study 
aimed at estimating age-related weights for health gains. Second, and related, the study 
sample did not include any children, primarily because it was restricted to the membership of 
the health care consumer panels of the recruiting social research company. One viewpoint is 
that society does not generally view children as autonomous legal, social and economic 
agents and, consequently, judges the values of children to be of limited relevance to social 
decision making. Our own viewpoint is that there is scope for incorporating the values of 
children with the necessary cognitive competences into social decision making deliberations 
in this area. Third, the measure of health gain for which we derived age-related weights was 
expressed in terms of years of life in full health. A valid concern that is that survey 
respondents could have interpreted the concept of full health differently for different stages of 
the age spectrum. Moreover, measuring health gains in terms of QALYs would arguably have 
been more informative to decision-makers. Nevertheless, our pilot research had demonstrated 
that disaggregating health gains in terms of life extensions and health-related quality of life 
improvements would have been cognitively challenging given the on-line format of the 
survey. Fourth, by setting the duration of health gain in the person trade-off questions at 
either 5 or 10 years, we controlled for ‘health maximisation ageism’ [28] or ‘utilitarian 
21 
 
ageism’ [31], the preference for the treatment of younger patients simply because they are 
expected to live longer after treatment. However, we are unable to assess whether the general 
preference for health gains for younger age groups over older age groups was primarily 
driven by ‘productivity ageism’[28], where preferences are determined by the recipients’ 
productivity potential, or ‘fair innings ageism’ [28] (or ‘egalitarian ageism’ [31]), where 
preferences are driven by an aversion to inequality in age of death. Disentangling these 
factors, and indeed other factors, within the preference structures of the study participants 
would have required detailed qualitative research. Fifth, although our study was based on a 
large sample of 2500 participants, the relatively small numbers of observations for each age 
comparison within age matrix 1 (e.g. 5 v 35, 20 v 65, etc.) and age matrix 2 (e.g. 10 v 30, 10 
v 70, etc.) limited the potential for regression analyses of the study data. We present in online 
appendix VI results of logistic regression analyses for ten random age comparisons. The 
probability of choosing the programme that saves lives among the older individuals was 
estimated in each logistic regression. The explanatory variables included the number of lives 
saved among younger individuals, the age of the lives of older individuals saved (entered as a 
dummy variable), and the age and sex of the respondent. A negative coefficient on the 
number of lives saved among younger individuals indicates that the programme that saves 
lives among older individuals is less attractive [44]. The sample sizes for each logistic 
regression numbered less than 100, but we present this appendix as an exemplar of how data 




In conclusion, this study has produced new evidence that should inform deliberations on 
whether health gains should be weighted according to age in health care decision-making. At 
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this stage, we consider it important that the results should be treated with caution, and subject 
to re-testing. In addition, future research should extend these analyses by estimating 
distributional weights for health gains according to combinations of characteristics of 
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Age (years); Mean(SD)  40.5(14.3) 
Gender; N(%)  
   Male 775(31.0) 
   Women  1725(69.0) 
Marital status; N(%)  
   Single (never married) 878(35.1) 
   Married, living with husband/wife 1280(51.2) 
   Civil partner  62(2.5) 
   Married and separated 66(2.6) 
   Divorced 167(6.7) 
   Widowed 
Ethnicity; N(%) 
   White  
   Mixed 
   Asian or Asian British 
   Black or Black British 
   Chinese/other/prefer not to say 
Employment; N(%) 
   Paid employment or self-employed 
   Unpaid work/unemployed 
   Full-time education 
   Permanently unable to work 
   Retired 
   Looking after home or family/other 















   <10,000 270(10.8) 
   10,000-20,000 509(20.4) 
   20,000-30,000 531(21.2) 
   30,000-40,000 430(17.2) 
   40,000-50,000 255(10.2) 
   >50,000 281(11.2) 
   Rather not say 224(9.0) 
Education (highest qualification); N(%)  
   Degree, teaching/nursing qualification and higher  510(20.4) 
   HNC/HND or equivalent  257(10.3) 
   A-level/AS-level/GCSE 1517(60.7) 
   Other  216(8.6) 
Have children; N(%)  
   Yes 1152(46.1) 
   No 







Self-reported general health: N(%) 
   Very good  







   Fair 
   Bad  
   Very bad 
Long-standing illness: N(%) 
   Yes  
   No 







   London 274(11.0) 
   South-East 425(17.0) 
   South-West 224(9.0) 
   Eastern 154(6.2) 
   East Midlands 186(7.4) 
   West Midlands 191(7.6) 
   Yorkshire 202(8.1) 
   North-West 283 (11.3) 
   North-East 102(4.1) 
   Wales 147(5.9) 
   Scotland 266(10.6) 
   North Ireland 46(1.8) 
‡  


































Table II: Distribution of age rank order assigned by study participants 
 
























Newborn 1359(54.4) 160(6.4) 102(4.1) 120(4.8) 97(3.9) 142(5.7) 153(6.1) 105(4.2) 110(4.4) 152(6.1) 19277 
10 432(17.3) 1210(48.5) 175(7.0) 162(6.5) 179(7.2) 134(5.4) 84(3.4) 35(1.4) 61(2.4) 28(1.1) 20079 
20 279(11.2) 390(15.6) 982(39.3) 156(6.2) 147(5.9) 116(4.6) 84(3.4) 92(3.7) 64(2.6) 190(7.6) 17640 
30 202(8.1) 291(11.6) 383(15.3) 930(37.2) 80(3.2) 99(4.0) 141(5.6) 97(3.6) 212(8.5) 65(2.6) 16532 
40 87(3.5) 160(6.4) 259(10.4) 360(14.4) 1033(41.3) 106(4.2) 114(4.6) 238(9.5) 95(3.8) 48(1.9) 15038 
50 43(1.7) 54(2.2) 142(5.7) 233(9.3) 388(15.5) 1200(48.0) 242(9.7) 78(3.1) 59(2.4) 61(2.4) 13392 
60 27(1.1) 46(1.8) 100(4.0) 157(6.3) 234(9.4) 490(19.6) 1334(53.4) 55(2.2) 32(1.3) 25(1.0) 12027 
70 15(0.6) 36(1.4) 105(4.2) 142(5.7) 226(9.0) 122(4.9) 269(10.8) 1551(62.0) 18(0.7) 16(0.6) 10055 
80 9(0.4) 51(2.0) 121(4.8) 196(7.8) 73(2.3) 44(1.8) 59(2.4) 203(8.1) 1732(69.3) 12(0.5) 7868 
90 47(1.9) 102(4.1) 131(5.2) 44(1.8) 43(1.7) 47(1.9) 20(0.8) 46(1.8) 117(4.7) 1903(76.1) 5592 
Modal rank is presented in bold. 
‡ Aggregate rankings summarised as Borda scores whereby the first through tenth ranked ages were given scores of ten through 1, and the scores summed  





Table III: Age Matrix 1: Relative age weights for 5 year life extensions: ratio of means method* and median of individual ratios method** 
 
 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 




















































































































































































































































































































































85                   2.28(0.44) 
2.86(0.35) 
90   
 
                 
 
0 denotes newborns. * Results for ratio of means methods are presented in upper half of each cell. ** Results for median of individual ratios method are presented in lower half of each cell. 
Left hand number in each cell reports relative weight for life extension by age group described by row headings, whilst right hand number reports relative weight for life extension by age group described by column headings; e.g., when comparing 20 year olds with 40 year olds using 
the ratio of means method, the relative weight for 5 year life extensions for 20 year olds is 1.10, whilst the relative weight for 5 year life extensions for 40 year olds is 0.91. 
33 
 
Table IV: Age Matrix 2: Relative age weights for 10 year life extensions: ratio of means method* and median of individual ratios method** 
 
 0 10 20 30 40 50 60 70 80 90 




























































































         
 
0 denotes newborns. * Results for ratio of means method are presented in upper half of each cell. ** Results for median of individual ratios method are presented in lower half of each cell. 
Left hand number in each cell reports relative weight for life extension by age group described by row heading, whilst right hand number reports relative weight for life extension by age group 
described by column heading; e.g., when comparing 20 year olds with 40 year olds using the ratio of means method, the relative weight for 10 year life extensions for 20 year olds is 1.31, whilst 





Table V: Relative age weights by period of life extension and analytical method 
 
Age 5 year life extensions 
 
10 year life extensions 
 


















Newborn 0.54 0.37 0.62 0.45 
5 0.81 0.85 \\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\ 
10 0.89 1.00 0.88 0.52 
15 0.91 0.51 \\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\ 
20 0.88 0.47 0.97 0.49 
25 0.91 0.58 \\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\ 
30 1.00 0.59 1.00 1.00 
35 0.95 0.36 \\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\ 
40 0.90 0.48 0.89 0.47 
45 0.90 0.41 \\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\ 
50 0.86 0.78 0.79 0.40 
55 0.89 0.43 \\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\ 
60 0.78 0.36 0.73 0.39 
65 0.70 0.23 \\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\ 
70 0.54 0.20 0.65 0.20 
75 0.60 0.16 \\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\ 
80 0.57 0.13 0.60 0.13 
85 0.56 0.13 \\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\ 
90 
\\\\\\\\\\\\\\\ 
\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\ 
±
 For the ratio of means method for the 5 and 10 year life extensions, 30 years of age was set as the referent as it emerged with the highest mean relative age weight across 
age comparisons in tables III and IV. 
†
 For the median of individual ratios method for 5 year life extensions, 10 years of age was set as the referent as it emerged with the highest mean relative age weight across 
age comparisons in table III; whilst for 10 year life extensions, 30 years of age was set as the referent as it emerged with the highest implied relative age weight across age 
comparisons in table IV.
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5 year life 
extensions 
 




20 v 40 6.84 2.89 0.16 
40 v 50 3.33 3.36 0.99 
60 v 80 0.32 0.32 0.99 
10 v 60 6.66 4.47 0.48 
40 v 80 0.80 2.36 0.31 
0 v 40 24.2 11.1 0.02 
40 v 70 1.57 2.25 0.71 
40 v 60 2.16 1.55 0.75 
0 v 80 7.54 4.04 0.31 
30 v 40 5.13 2.76 0.39 
10 v 70 5.82 0.74 0.03 
20 v 30 2.40 3.57 0.54 
10 v 40 9.24 4.49 0.16 
30 v 70 0.70 1.52 0.47 
10 v 20 5.34 10.17 0.18 
0 v 30 24.20 15.21 0.10 
10 v 50 3.66 5.15 0.49 
10 v 90 5.38 4.35 0.75 
50 v 90 2.05 1.38 0.75 
10 v 80 4.00 0.23 0.06 
 
* Student’s t test procedure with unequal variance was used to test individual-level mean ratio differences  
by period of life extension. Analyses restricted to individuals for whom both 5 year and 10 year life  























Table VII: Summary statistics for PTO weights and ICCs for PTO questions: test-retest analysis 
 





All subjects (n=500) 
1
st
  500 178(276) 184(274) 0.82 <0.001 
2
nd
  500 201(297) 209(292) 0.88 <0.001 
3
rd
  500 219(301) 221(297) 0.50 <0.001 
4
th
  500 217(303) 227(311) 0.90 <0.001 
5
th
  500 201(292) 212(305) 0.93 <0.001 
6
th
  500 195(285) 208(297) 0.88 <0.001 
7
th
  500 162(265) 174(267) 0.84 <0.001 
8
th
  500 182(278) 184(275) 0.85 <0.001 
Subjects with referent of 100 individuals (n=250) 
1
st
  250 33(32) 39(35) 0.75 <0.001 
2
nd
  250 34(34) 38(33) 0.82 <0.001 
3
rd
  250 39(34) 42(35) 0.79 <0.001 
4
th
  250 39(35) 42(36) 0.86 <0.001 
5
th
  250 38(34) 40(34) 0.88 <0.001 
6
th
  250 36(35) 40(35) 0.86 <0.001 
7
th
  250 31(32) 33(33) 0.79 <0.001 
8
th
  250 36(34) 37(34) 0.81 <0.001 
Subjects with referent of 1000 individuals (n=250) 
1
st
  250 323(331) 330(327) 0.74 <0.001 
2
nd
  250 369(345) 380(334) 0.80 <0.001 
3
rd
  250 399(340) 401(334) 0.77 <0.001 
4
th
  250 395(346) 413(351) 0.83 <0.001 
5
th
  250 364(342) 384(355) 0.89 <0.001 
6
th
  250 352(334) 377(344) 0.82 <0.001 
7
th
  250 294(324) 316(319) 0.77 <0.001 
8
th
  250 329(333) 331(327) 0.78 <0.001 
ICC denotes intraclass correlation coefficient. 
































Study Participants: <40 Year Olds





























































































































On-line Appendix I: Example of Person Trade-Off Question 
 
Now we are going to take you through an example of a prioritisation exercise we would like 
you to complete. Imagine you are in a position where you have to choose between two health 
care programmes.  Both programmes would extend the lives of patients who would otherwise 
die immediately if they were not treated. Both programmes cost the same amount, but you 
cannot provide both. 
 
Programme A would be targeted at patients who are 20 years old. It would allow them to live 
in full health for an extra 5 years after which they die. 
 
Programme B would be targeted at patients who are 55 years old. It would allow them to live 
in full health for an extra 5 years after which they die. 
 
Now would you give priority to: 
EITHER 
Programme A which would extend the lives of 100 20 year olds for an extra 5 years after 
which they die  
OR 
Programme B which would extend the lives of 100 55 year olds for an extra 5 years after 
which they die  
 
• Programme A  • Programme B 
 
 
(If A is selected) 
What if fewer than 100 20 years old could be treated for that amount of money? 
Now would you give priority to: 
 
Programme A which would extend the lives of 60 20 year olds for an extra 5 years after 
which they die  
OR 
Programme B which would extend the lives of 100 55 year olds for an extra 5 years after 
which they die  
 
• Programme A  • Programme B 
 
(If B is selected) 
What if fewer than 100 55 years old could be treated for that amount of money? 
Now would you give priority to: 
 
Programme A which would extend the lives of 100 20 year olds for an extra 5 years after 
which they die  
OR 
Programme B which would extend the lives of 60 55 year olds for an extra 5 years after 
which they die  
 
• Programme A  • Programme B 
___________________________________________________________________________ 
In both cases a ping pong exercise ensued until the point of indifference was reached. 
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On-line Appendix II: Examples of aggregation of person trade-off ratios 
 
Respondent No. of individuals at 
indifference point 
Ratio of means 
method 
Median of individual 
ratios method 
Age A Age B Age A Age B Ratio A/B Ratio B/A 
1 100 50 0.5 1 2 0.5 
2 100 80 0.8 1 1.25 0.8 
3 100 60 0.6 1 1.67 0.6 
4 100 50 0.5 1 2 0.5 
5 100 80 0.8 1 1.25 0.8 
6 50 100 1 0.5 0.5 2 
7 90 100 1 0.9 0.9 1.11 
8 70 100 1 0.7 0.7 1.43 
9 50 100 1 0.5 0.5 2 
 
Ratio of means method: mean value for age A is 0.800, whilst the mean value for age B is 
0.844. The implied weight of age B relative to age A is 0.844/0.800, i.e. 1.055. Alternatively, 
implied weight of age A relative to age B is 0.800/0.844, i.e. 0.948. The measure is 
symmetrical, i.e. 1/1.055 equals 0.948. 
 
Median of individual ratios method: the median of individual ratios for age A relative to age 
B is 1.25. Alternatively, the median of individual ratios for age B relative to age A is 0.8. The 


































































































































Online Appendix IV: Results of chaining tests for relative age weights 
 
Age group comparison Direct result Chained result 
0 v 10 0.66 0.64 
5 v 15 1.15 1.19 
10 v 20 1.20 1.24 
25 v 35 1.14 1.07 
30 v 50 1.50 1.79 
40 v 60 2.16 2.33 
50 v 70 2.89 3.10 
20 v 40 1.31 1.29 
50 v 80 3.02 7.06 
45 v 55 1.50 1.65 
55 v 65 1.69 1.56 
60 v 80 3.45 4.33 
0 v 20 0.61 0.71 
65 v 75 1.93 1.65 
35 v 45 1.26 1.34 
70 v 90 4.08 6.53 
30 v 40 1.23 1.24 
50 v 60 1.50 1.55 
65 v 75 1.93 1.65 




Online Appendix V: Comparison of relative weights for health gains by reference 
number of individuals (100 v 1000) and period of life extension (5 v 10 years)* 
 























30 v 85 0.26 2.20 0.34 20 v 40 1.78 3.70 0.34 
40 v 50 3.18 3.51 0.93 40 v 50 3.57 3.01 0.86 
50 v 60 0.77 0.70 0.60 60 v 80 0.29 0.36 0.45 
60 v 90 0.17 0.15 0.74 10 v 60 5.54 2.90 0.48 
65 v 80 0.33 2.86 0.33 40 v 80 4.26 0.41 0.18 
30 v 40 6.34 3.80 0.60 0 v 40 8.51 13.64 0.37 
0 v 60 14.20 8.86 0.40 40 v 70 2.35 2.17 0.95 
20 v 60 6.78 0.52 0.14 40 v 60 0.43 2.53 0.29 
5 v 60 7.41 8.26 0.88 0 v 80 3.98 4.12 0.97 
0 v 40 24.39 24.07 0.97 30 v 40 1.50 3.62 0.31 
25 v 55 5.69 0.86 0.08 10 v 70 1.04 0.40 0.32 
65 v 90 7.60 0.17 0.08 20 v 30 1.74 5.18 0.15 
20 v 50 2.20 0.87 0.33 10 v 40 2.45 7.08 0.20 
25 v 75 1.84 2.14 0.89 30 v 70 2.71 0.31 0.26 
45 v 60 0.53 2.81 0.27 10 v 20 10.70 9.55 0.82 
5 v 85 6.93 5.11 0.64 0 v 30 11.51 20.24 0.15 
65 v 75 0.71 1.99 0.40 10 v 50 7.70 2.56 0.10 
60 v 80 0.37 0.27 0.24 10 v 90 5.38 3.66 0.69 
10 v 25 8.51 6.25 0.64 50 v 90 0.87 1.85 0.58 
0 v 30 21.28 27.79 0.49 10 v 80 0.22 0.23 0.89 
*Relative age weights estimated using the ratio of means method. 
‡ 





Online Appendix VI: Results of logistic regression analyses of choosing the programme 
that saves older individuals 
 




P-value 95% Confidence 
interval 
ln lives saved among 20 year olds -0.0938 0.3409 0.783 -0.7620 0.5742 
Age of older individuals saved 0.4838 0.8898 0.587 -1.2602 2.2280 
Age of respondent 0.0244 0.0239 0.307 -0.0224 0.0713 
Male gender -1.1222 0.9686 0.247 -3.0208 0.7762 
Constant -0.9158 1.4512 0.528 -3.7602 1.9285 
* The reference number of individuals in each person trade-off question was 100. 
 




P-value 95% Confidence 
interval 
ln lives saved among 20 year olds -0.9246 0.7600 0.224 -2.4143 0.5651 
Age of older individuals saved 1.4702 3.1777 0.644 -4.7580 7.6985 
Age of respondent 0.0283 0.0271 0.297 -0.0248 0.0815 
Male gender 0.4267 0.8341 0.609 -1.2081 2.0615 
Constant 1.7835 2.3067 0.439 -2.7377 6.3047 
* The reference number of individuals in each person trade-off question was 1000. 
 




P-value 95% Confidence 
interval 
ln lives saved among 40 year olds -0.2568 0.4633 0.579 -1.1649 0.6512 
Age of older individuals saved 0.9008 1.4168 0.525 -1.8762 3.6778 
Age of respondent 0.03713 0.0323 0.250 -0.0261 0.1004 
Male gender -0.4016 1.0296 0.697 -2.4196 1.6164 
Constant -3.0038 2.1633 0.165 -7.2438 1.2361 
 




P-value 95% Confidence 
interval 
ln lives saved among 40 year olds 1.6121 1.3603 0.236 -1.0541 4.2784 
Age of older individuals saved -6.7438 5.3987 0.212 -17.3251 3.8373 
Age of respondent 0.0443 0.0344 0.198 -0.0232 0.1118 
Male gender 1.4974 1.3918 0.282 -1.2305 4.2255 
Constant -8.9435 4.7490 0.060 -18.2515 0.3643 
 




P-value 95% Confidence 
interval 
ln lives saved among 10 year olds 0.3667 0.3434 0.286 -0.3063 1.0398 
Age of older individuals saved -1.1581 1.3748 0.400 -3.8527 1.5365 
Age of respondent 0.0598 0.0305 0.050 0.0000 0.1198 
Male gender 0.9962 0.8331 0.232 -0.6366 2.6291 












P-value 95% Confidence 
interval 
ln lives saved among 10 year olds 0.4043 0.6845 0.555 -0.9372 1.7459 
Age of older individuals saved -0.1650 2.2008 0.940 -4.4786 4.1485 
Age of respondent 0.1341 0.0531 0.012 0.0300 0.2382 
Male gender -0.6914 1.0137 0.495 -2.6783 1.2954 
Constant -8.0276 3.5913 0.025 -15.0666 -0.9886 
 




P-value 95% Confidence 
interval 
ln lives saved among newborns -0.5613 0.3361 0.095 -1.2203 0.0975 
Age of older individuals saved 0.8232 1.2764 0.519 -1.6786 3.3250 
Age of respondent 0.1114 0.0448 0.013 0.0234 0.1993 
Male gender -0.6892 1.0581 0.515 -2.7632 1.3846 
Constant -2.3366 1.5251 0.126 -5.3259 0.6526 
 




P-value 95% Confidence 
interval 
ln lives saved among newborns 0.6885 0.6898 0.318 -0.6634 2.0405 
Age of older individuals saved -2.1709 2.6892 0.420 -7.4418 3.0998 
Age of respondent 0.0852 0.0411 0.038 0.0045 0.1659 
Male gender 0.4758 0.8706 0.585 -1.2306 2.1823 
Constant -4.7010 2.4417 0.585 -9.4867 0.0846 
 




P-value 95% Confidence 
interval 
ln lives saved among newborns 1.1815 0.5313 0.026 0.1400 2.2230 
Age of older individuals saved -3.3821 2.0313 0.096 -7.3634 0.5992 
Age of respondent 0.1003 0.0482 0.037 0.0058 0.1948 
Male gender 0.7069 1.0845 0.515 -1.4187 2.8326 
Constant -6.9125 2.8835 0.017 -12.5641 -1.2608 
 




P-value 95% Confidence 
interval 
ln lives saved among newborns 1.6157 0.9839 0.101 -0.3128 3.5443 
Age of older individuals saved -4.5825 3.9543 0.247 -12.3329 3.1679 
Age of respondent 0.0012 0.0375 0.973 -0.0723 0.0748 
Male gender 0.4702 0.0375 0.732 -2.2198 3.1604 
Constant -5.9782 2.8195 0.034 -11.5045 -0.4520 
 




P-value 95% Confidence 
interval 
ln lives saved among 30 year olds -0.4319 0.4433 0.330 -1.3008 0.4370 
Age of older individuals saved 0.7434 1.4366 0.605 -2.0722 3.5591 
Age of respondent 0.0772 0.0367 0.035 0.0052 0.1491 
Male gender -0.7388 1.041 0.478 -2.7803 1.3025 








P-value 95% Confidence 
interval 
ln lives saved among 30 year olds 0.7684 1.2344 0.534 -1.6509 3.1878 
Age of older individuals saved -2.9125 5.3616 0.587 -13.4211 7.5960 
Age of respondent -0.0382 0.0348 0.272 -0.1065 0.0300 
Male gender 2.2472 1.0959 0.040 0.0992 4.3952 
Constant -2.5882 3.5426 0.465 -9.5318 4.3552 
 




P-value 95% Confidence 
interval 
ln lives saved among 10 year olds 0.2213 0.4017 0.582 -0.5661 1.0088 
Age of older individuals saved 0.4814 1.3174 0.715 -2.1006 3.0635 
Age of respondent 0.0236 0.0393 0.547 -0.0533 0.1006 
Male gender 0.8762 0.9055 0.333 -0.8986 2.651 
Constant -3.4344 2.0027 0.086 -7.3597 0.4907 
 




P-value 95% Confidence 
interval 
ln lives saved among 10 year olds 1.0557 0.5740 0.066 -0.0693 2.1808 
Age of older individuals saved -2.4761 2.0893 0.236 -6.5711 1.6189 
Age of respondent 0.0668 0.0315 0.034 0.0050 0.1286 
Male gender -1.1570 0.9772 0.236 -3.0723 0.7582 
Constant -7.0172 2.4879 0.005 -11.8936 -2.1408 
 




P-value 95% Confidence 
interval 
ln lives saved among 10 year olds -0.2904 0.3015 0.336 -0.8814 -3.2546 
Age of older individuals saved 0.4886 0.9505 0.607 -1.3744 2.3517 
Age of respondent 0.0169 0.0336 0.614 -0.0489 0.0828 
Male gender -0.2918 0.7513 0.698 -1.7644 1.1807 
Constant -0.4165 1.4480 0.774 -3.2546 2.4216 
 




P-value 95% Confidence 
interval 
ln lives saved among 10 year olds -0.4964 0.5354 0.354 -1.5459 0.5530 
Age of older individuals saved 2.1301 1.9508 0.275 -1.6935 5.9538 
Age of respondent 0.0376 0.0251 0.134 -0.0116 0.0870 
Male gender -0.0386 0.7318 0.958 -1.4730 1.3958 
Constant -1.1942 1.8854 0.526 -4.8897 2.5011 
 




P-value 95% Confidence 
interval 
ln lives saved among 10 year olds -0.2545 0.4093 0.534 -1.0568 0.5476 
Age of older individuals saved 2.1639 1.3725 0.115 -0.5261 4.8540 
Age of respondent -0.0228 0.0324 0.482 -0.0865 0.0408 
Male gender 1.1692 1.0570 0.269 -0.9024 3.2409 








P-value 95% Confidence 
interval 
ln lives saved among 10 year olds -1.0540 0.7359 0.152 -2.4964 0.3884 
Age of older individuals saved 4.8290 2.9214 0.098 -0.8968 10.5549 
Age of respondent 0.0531 0.0363 0.143 -0.0180 0.1244 
Male gender 0.6609 0.9230 0.474 -1.1481 2.4701 
Constant -0.7444 2.4959 0.765 -5.6364 4.1474 
 




P-value 95% Confidence 
interval 
ln lives saved among newborns -0.0346 0.2523 0.891 -0.5292 0.4599 
Age of older individuals saved 0.9413 1.0114 0.352 -1.0410 2.9238 
Age of respondent 0.0613 0.0318 0.054 -0.0010 .12384 
Male gender -0.3239 0.7107 0.649 -1.7169 1.0691 
Constant -1.4830 1.3883 0.285 -4.2042 1.2381 
 




P-value 95% Confidence 
interval 
ln lives saved among newborns -0.8638 0.7475 0.248 -2.3290 0.6013 
Age of older individuals saved 2.6270 2.7908 0.347 -2.8429 8.0970 
Age of respondent -0.0138 0.0274 0.613 -0.0676 0.0398 
Male gender -0.6521 0.7619 0.392 -2.1454 0.8412 
Constant 3.5883 2.3823 0.132 -1.0809 8.2577 
 
 
 
 
